share_log

HC Wainwright & Co. Initiates Coverage On ImmunoPrecise Antibodies With Buy Rating, Announces Price Target of $9

Benzinga Real-time News ·  Dec 2, 2022 06:34

HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy rating and announces Price Target of $9.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment